Alexandra Esteves , Andreia Henriques , Beatriz Fernandes , Pedro Fragoso , Clara Pardinhas , Marina Reis , Rita Leal , Luís Rodrigues , Maria Guedes Marques , Lídia Santos , Catarina Romãozinho , Helena Sá , Arnaldo Figueiredo
{"title":"肾移植后新发系统性红斑狼疮1例。","authors":"Alexandra Esteves , Andreia Henriques , Beatriz Fernandes , Pedro Fragoso , Clara Pardinhas , Marina Reis , Rita Leal , Luís Rodrigues , Maria Guedes Marques , Lídia Santos , Catarina Romãozinho , Helena Sá , Arnaldo Figueiredo","doi":"10.1016/j.transproceed.2025.07.015","DOIUrl":null,"url":null,"abstract":"<div><div>The diagnosis of new onset autoimmune diseases in kidney transplant patients is challenging with new onset SLE after kidney transplant being a rare condition, with very few cases reported. We describe a case of a kidney transplant patient who, after 9 years presented with intermittent fever and diarrhea, inflammatory migratory polyarthralgia, myalgias, cramps and an erythematous rash in the cleavage area. Immunological testing revealed positive antinuclear antibodies (ANA 1:640), anti–double-stranded DNA antibodies (53.2 IU/mL), and elevated beta-2 microglobulin (105.59 U/mL), leading to the diagnosis of de novo SLE according to EULAR/ACR 2019 criteria. Notably, the patient exhibited no evidence of renal involvement from the onset, with stable kidney function and normal urinary sediment throughout follow-up. Ten months after undergoing treatment with corticosteroids and belimumab there was partial clinical and serological improvement. This case highlights a rare presentation of post-transplant SLE without renal involvement, reinforcing the need for a high index of suspicion in transplant recipients presenting with non-specific inflammatory symptoms.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"57 7","pages":"Pages 1300-1302"},"PeriodicalIF":0.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Onset Systemic Lupus Erythematous After Kidney Transplant: Case Report\",\"authors\":\"Alexandra Esteves , Andreia Henriques , Beatriz Fernandes , Pedro Fragoso , Clara Pardinhas , Marina Reis , Rita Leal , Luís Rodrigues , Maria Guedes Marques , Lídia Santos , Catarina Romãozinho , Helena Sá , Arnaldo Figueiredo\",\"doi\":\"10.1016/j.transproceed.2025.07.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The diagnosis of new onset autoimmune diseases in kidney transplant patients is challenging with new onset SLE after kidney transplant being a rare condition, with very few cases reported. We describe a case of a kidney transplant patient who, after 9 years presented with intermittent fever and diarrhea, inflammatory migratory polyarthralgia, myalgias, cramps and an erythematous rash in the cleavage area. Immunological testing revealed positive antinuclear antibodies (ANA 1:640), anti–double-stranded DNA antibodies (53.2 IU/mL), and elevated beta-2 microglobulin (105.59 U/mL), leading to the diagnosis of de novo SLE according to EULAR/ACR 2019 criteria. Notably, the patient exhibited no evidence of renal involvement from the onset, with stable kidney function and normal urinary sediment throughout follow-up. Ten months after undergoing treatment with corticosteroids and belimumab there was partial clinical and serological improvement. This case highlights a rare presentation of post-transplant SLE without renal involvement, reinforcing the need for a high index of suspicion in transplant recipients presenting with non-specific inflammatory symptoms.</div></div>\",\"PeriodicalId\":23246,\"journal\":{\"name\":\"Transplantation proceedings\",\"volume\":\"57 7\",\"pages\":\"Pages 1300-1302\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation proceedings\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041134525003574\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041134525003574","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
New Onset Systemic Lupus Erythematous After Kidney Transplant: Case Report
The diagnosis of new onset autoimmune diseases in kidney transplant patients is challenging with new onset SLE after kidney transplant being a rare condition, with very few cases reported. We describe a case of a kidney transplant patient who, after 9 years presented with intermittent fever and diarrhea, inflammatory migratory polyarthralgia, myalgias, cramps and an erythematous rash in the cleavage area. Immunological testing revealed positive antinuclear antibodies (ANA 1:640), anti–double-stranded DNA antibodies (53.2 IU/mL), and elevated beta-2 microglobulin (105.59 U/mL), leading to the diagnosis of de novo SLE according to EULAR/ACR 2019 criteria. Notably, the patient exhibited no evidence of renal involvement from the onset, with stable kidney function and normal urinary sediment throughout follow-up. Ten months after undergoing treatment with corticosteroids and belimumab there was partial clinical and serological improvement. This case highlights a rare presentation of post-transplant SLE without renal involvement, reinforcing the need for a high index of suspicion in transplant recipients presenting with non-specific inflammatory symptoms.
期刊介绍:
Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication.
The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics.
Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the Editorial Board.
Original basic or clinical science articles, clinical trials and case studies can be submitted to the journal?s open access companion title Transplantation Reports.